162 related articles for article (PubMed ID: 22039305)
1. Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses.
Denton AE; Wesselingh R; Gras S; Guillonneau C; Olson MR; Mintern JD; Zeng W; Jackson DC; Rossjohn J; Hodgkin PD; Doherty PC; Turner SJ
J Immunol; 2011 Dec; 187(11):5733-44. PubMed ID: 22039305
[TBL] [Abstract][Full Text] [Related]
2. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
Ma H; Kapp JA
Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
[TBL] [Abstract][Full Text] [Related]
3. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
Curtsinger JM; Lins DC; Mescher MF
J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxic T lymphocyte response against a protein antigen does not decrease the antibody response to that antigen although antigen-pulsed B cells can be targets.
Wang W; Golding B
Immunol Lett; 2005 Sep; 100(2):195-201. PubMed ID: 15916814
[TBL] [Abstract][Full Text] [Related]
6. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
7. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
Dillon SR; Jameson SC; Fink PJ
J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
Maecker HT; Umetsu DT; DeKruyff RH; Levy S
J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific activation thresholds of CD8+ T cells are independent of IFN-I-mediated partial lymphocyte activation.
Wijesundara DK; Kumar S; Alsharifi M; Müllbacher A; Regner M
Int Immunol; 2010 Sep; 22(9):757-67. PubMed ID: 20682547
[TBL] [Abstract][Full Text] [Related]
10. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.
Ishioka GY; Colon S; Miles C; Grey HM; Chesnut RW
J Immunol; 1989 Aug; 143(4):1094-100. PubMed ID: 2787356
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T-cell response following mouse liver transplantation is independent of the initial site of T-cell priming.
Klein I; Gassel HJ; Crispe IN
Transplant Proc; 2006 Dec; 38(10):3241-3. PubMed ID: 17175235
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
[TBL] [Abstract][Full Text] [Related]
13. Visualizing CTL activity for different CD8+ effector T cells supports the idea that lower TCR/epitope avidity may be advantageous for target cell killing.
Jenkins MR; La Gruta NL; Doherty PC; Trapani JA; Turner SJ; Waterhouse NJ
Cell Death Differ; 2009 Apr; 16(4):537-42. PubMed ID: 19136939
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs.
Hauser C; Zipprich F; Leblond I; Wirth S; Hügin AW
J Immunol; 1999 Jul; 163(1):330-6. PubMed ID: 10384132
[TBL] [Abstract][Full Text] [Related]
15. Activation of CD8-dependent cytotoxic T lymphocyte adhesion and degranulation by peptide class I antigen complexes.
Kane KP; Mescher MF
J Immunol; 1993 Jun; 150(11):4788-97. PubMed ID: 8496589
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
[TBL] [Abstract][Full Text] [Related]
17. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
[TBL] [Abstract][Full Text] [Related]
18. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
19. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.
Yokouchi H; Chamoto K; Wakita D; Noguchi D; Yamazaki K; Dosaka-Akita H; Nishimura M; Ikeda H; Nishimura T
Cancer Sci; 2006 Feb; 97(2):148-54. PubMed ID: 16441426
[TBL] [Abstract][Full Text] [Related]
20. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
Lipford GB; Hoffman M; Wagner H; Heeg K
J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
